JUNE 2015

NTSAD 2015 Research Grants Awarded
Five Projects Funded to Further Research
Over $266,000 in grants were awarded this spring to five research projects. The grants were made for a one to two year period for up to $40,000 a year. These projects represent NTSAD's commitment to fund research that will lead to treatments for rare genetic diseases such as Tay-Sachs, Canavan, GM1 and Sandhoff diseases.

Grants were made for the following proposals:

Development and Validation of a Rapid MS/MS-based Method to Detect HexA deficiency in Tay-Sachs disease
Principal Investigator: Denis Lehotay, PhD
University of Saskatchewan College of Medicine

Intravascular Gene Therapy for Feline GM2
Principal Investigator: Douglas Martin, PhD
Auburn University

Generation of a Knock-in Mutant Hexb Mouse Model
Principal Investigator: Eric Sjoberg
OrPhi Therapeutics

Late Onset Registry and Repository
Principal Investigator: Florian Eichler, MD
Massachusetts General Hospital

Defining Natural History of Canavan Disease through the Development of an International Registry
Co-funded with The Canavan Foundation
Principal Investigator: Heather Lau, MD, MS
Co-Investigator: Paola Leone, PhD
New York University

 
Inspired to Take Action 
It All Starts with a Spark
by Scott Hunger, Esq., MBA

What you may have known is that I sat on the NTSAD Board of Directors in a few recent years and have been friends with many of you for many more years than that.  What you probably didn't know however, is that at this year's NTSAD Annual Family Conference, a presentation on fundraising really sparked my personal interest in Advocacy and may be a catalyst for the future development of an NTSAD Advocacy Program focused on educating and influencing national political figures about NTSAD and perhaps even sparking a national conversation on rare/orphan diseases, which are nationally represented by NTSAD.


While listening carefully to Stephanie Bozarth's (President, National MPS Society) presentation on advocacy at the NTSAD fundraising discussion during this year's NTSAD Family Conference, I was inspired to help develop a similar Advocacy Program for NTSAD, through which national political figures can be educated about NTSAD.  While I think that it is certainly true that the conditions which NTSAD represents are small in terms of the numbers of affected individuals and families. Perhaps that explains much of the reason why it has recently been so difficult and an uphill struggle to get private industry and governmental support for funding research and development for potential solutions to many of the challenges families affected by the conditions which NTSAD represents. I also think it is an undeniable truth that once they are educated about these conditions, nationally elected politicians will find it very difficult to oppose public support for organizations like NTSAD.

 

This, I think, is the key.....making nationally elected political representatives aware of the conditions which are represented by organizations such as NTSAD. I hope to soon learn about how to put this type of advocacy in motion for NTSAD by learning about Ms. Bozarth's advocacy on behalf of the National MPS Society.


Click below and read about another parent's advocacy story in last week's "Topic of the Week" 


 

NTSAD's Annual Fund Campaign
Caring for Families, Finding a Cure
This month, NTSAD is sharing stories of different families coping with GM1, Canavan, Late Onset Sandhoff and Tay-Sachs diseases. They represent the nearly 1,000 families worldwide that NTSAD supports from diagnosis, to actively caring for their child and through the grief.

A gift to NTSAD's Annual Fund supports family services, carrier screening education for the public and for health professionals, and legislative advocacy as it relates to the rare disease community. 

IN THIS ISSUE
Need Your Help!


NTSAD's partner in screening and awareness, The Jewish Genetic Disease Consortium (JGDC) is undertaking an important new project. It has come to our attention that Kaiser Permanente (California's largest health insurer) has an inadequate carrier screening policy for the Jewish genetic diseases. Currently, screening is only offered to patients if both partners within a couple are Jewish. The couple will then be offered screening for only four (4) diseases (Cystic Fibrosis, Tay-Sachs, Canavan and Familial Dysautonmia). Sadly, as we all know, carriers are going undetected and children are born with these devastating diseases.

The JGDC plans to set up a meeting with Kaiser Permanente to present a heartfelt program detailing the reasons why their screening policy needs to change.

Please contact Shari Ungerleider at her email here if you are or were a Kaiser patient who was not offered screening or if inadequate screening was offered.

KEEPING BUSY
Author and Candidate

NTSAD Late Onset Tay-Sachs community member Cary Berman's book, "Genesis: Born with Tay-Sachs" will soon be published by Infinity Publishing. He also recently announced that he is running for Congress in the 9th district of Illinois! Stay tuned to follow Cary's story in the months to come.
Stay Connected

Like us on Facebook  Follow us on Twitter  View our videos on YouTube
make a gift here. thank you.

 national tay-sachs & allied diseases association (ntsad)
 susan kahn, executive director ([email protected])
2001 beacon street
 joan lawrence, development director ([email protected])
suite 204
 diana pangonis, family services & communications director ([email protected])
boston, ma 02135
 ingrid miller, office manager ([email protected])
(617) 277-4463
 becky benson, conference coordinator ([email protected])
www.NTSAD.org